2023

1. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

   Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437